BOH (drug)

BOH
Clinical data
Other namesβ-MeO-MDPEA; β-Methoxy-MDPEA; 3,4-Methylenedioxy-β-methoxyphenethylamine
MedlinePlusa609035
Routes of
administration		Oral[1]
ATC code
  • None
Legal status
Legal status
Identifiers
IUPAC name
  • 2-(1,3-benzodioxol-5-yl)-2-methoxyethanamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H13NO3
Molar mass195.218 g·mol−1
3D model (JSmol)
SMILES
  • NCC(OC)c1ccc2OCOc2c1
InChI
  • InChI=1S/C10H13NO3/c1-12-10(5-11)7-2-3-8-9(4-7)14-6-13-8/h2-4,10H,5-6,11H2,1H3 checkY
  • Key:KUTKTMOZFCYDLZ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

BOH, also known as 3,4-methylenedioxy-β-methoxyphenethylamine or as β-MeO-MDPEA, is a drug of the phenethylamine and BOx families.[1] It is the β-methoxy analog of methylenedioxyphenethylamine (MDPEA) and is also more distantly related to methylone. On account of its similarity to norepinephrine, the effects of BOH may be of a purely adrenergic nature.[1]

Use and effects

BOH was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, the dosage range is listed as 80–120 mg, and the duration listed as 6–8 hours. Shulgin reports that BOH causes slight warmth, mydriasis, anorexia, mild nausea, and cold feet, with no psychedelic, entactogen, or euphoriant effects.[1] He gives it a ++ on the Shulgin Rating Scale.[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. 1 2 3 4 5 6 Shulgin A, Shulgin A (1991). Pihkal: A Chemical Love Story. Transform Press. ISBN 0-9630096-0-5.
  2. ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
This article is issued from WikiProjectMed. The text is available under Creative Commons Attribution-ShareAlike License unless otherwise noted. Additional terms may apply for the media files.